| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
Description: 19-nor-progesterone derivative; structure given in UD
Also Known As:| 1. | Belkahia, Chelbi: 1 article (01/2004) |
| 2. | Daghfous, Riadh: 1 article (01/2004) |
| 3. | Hédi Loueslati, Mohamed: 1 article (01/2004) |
| 4. | El Aidli, Sihem: 1 article (01/2004) |
| 5. | Rjeibi, Imène: 1 article (01/2004) |
| 6. | Lakhal, Mohamed: 1 article (01/2004) |
| 1. | Dyslipidemias (Dyslipidemia)
12/01/1998
- "In this study including 26 patients with dyslipoproteinemia classified IIa, we evaluated biochemical and clinical safety of Nomegestrol acetate (Lutenyl) used for its antigonadotrophin property"
Order ALL the reference details at left... |
| 2. | Hepatitis
01/01/2004
- "Nome gesrol (lutenyl) induced severe acute hepatitis]"
Order ALL the reference details at left... |
| 3. | Hemorrhage
01/04/1999
- "RESULTS: No significant differences were found in the mean interval between the last dose of nomegestrol and the start of bleeding or in the duration of bleeding"
Order ALL the reference details at left... |
| 1. | nomegestrol acetate
|
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
| Price: | $490.00
access via web interface 1 year subscription |
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |